insights_auto
Why is O15 up 5.07%?
Dive Deeperchevron_right
O15:FRA
Insilico Medicine Cayman TopCo
€4.56
arrow_upward
+5.07%(+0.22) 1D
Oct 16, 10:00:00 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for O15...
Open
€4.44
High
€4.56
Low
€4.38
Mkt. cap
22.88B
Avg. vol.
2.46K
Volume
4.15K
52-wk high
€9.00
52-wk low
€3.58
No. of employees
333
Open
€4.44
High
€4.56
Low
€4.38
Mkt. cap
22.88B
Avg. vol.
2.46K
Volume
4.15K
52-wk high
€9.00
52-wk low
€3.58
No. of employees
333
News stories
From web sources and news partners
Fox Business
·
9 hours ago
Medical company bets on AI-powered drug breakthrough that could extend lifespan to 150
Profile
Insilico Medicine is a biotechnology company headquartered in Boston, Massachusetts, with additional facilities in Pak Shek Kok, Hong Kong in Hong Kong Science Park near the Chinese University of Hong Kong, and in New York, at The Cure by Deerfield. The company applies genomics, big data analysis, and deep learning for in silico drug discovery. Wikipedia
About Insilico Medicine Cayman TopCo
CEOFeng Ren | Alex Zhavoronkov
Employees333
Founded2014
Headquarters-
SectorHealth care
Websiteinsilico.com